Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Analysis of plasma HtrA1 concentrations in age-related macular degeneration

Sofie Clasina Anna ten Brink; Bjorn Bakker; Carel C B Hoyng; Yara T E Lechanteur; Caroline C W Klaver; Anneke I Den Hollander

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):477 – A0014. doi:

ARVO Annual Meeting Abstract June 2022

Equivalent choroidal thicknesses between eyes of patients with unilateral neovascular age-related macular degeneration who have been treated with anti-vascular endothelial growth factor: a paired eyes comparative study

Francesco Cinque; Femke van den Tillaart; Caroline C W Klaver; Carel C B Hoyng; Yara T E Lechanteur

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):340 – F0171. doi:

ARVO Annual Meeting Abstract June 2022

Rare variants in CFH and phenotype in Age-related Macular Degeneration in the Coimbra Eye Study.

Claudia Farinha; Patrícia Barreto; Rita Coimbra; Adela Lutis; Maria Luz Cachulo; Jose G Cunha-Vaz; Yara T E Lechanteur; Carel C B Hoyng; Rufino Silva

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):330 – F0161. doi:

ARVO Annual Meeting Abstract June 2021

Supplement intake and plasma nutritional biomarkers reduce risk for second eye progression in age-related macular degeneration.

Yara T E Lechanteur; Thomas J Heesterbeek; Anneke I Den Hollander; Laura Lores de Motta; Ilhan E Acar; Eiko K de Jong; B. Jeroen Klevering; Caroline C. W. Klaver; Carel Hoyng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):347. doi:

Retina March 2020

Complement Activation Levels Are Related to Disease Stage in AMD

PDF

Thomas J. Heesterbeek; Yara T. E. Lechanteur; Laura Lorés-Motta; Tina Schick; Mohamed R. Daha; Lebriz Altay; Sandra Liakopoulos; Dzenita Smailhodzic; Anneke I. den Hollander; Carel B. Hoyng; Eiko K. de Jong; B. Jeroen Klevering
TAGS: complement activation, complement system proteins, choroidal neovascularization
Invest. Ophthalmol. Vis. Sci.. 2020; 61(3):18. doi: https://doi.org/10.1167/iovs.61.3.18

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Subclinical choroidal neovascularizations in fellow-eyes of exudative age-related macular degeneration patients show a decrease in retinal sensitivity over time

Thomas Johannes Heesterbeek; Yara Lechanteur; Anita de Breuk; Anneke I Den Hollander; Jeroen Klevering; Thomas Theelen; Carel C B Hoyng

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3484. doi:

Biochemistry and Molecular Biology December 2015

Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration

PDF

Constantin C. Paun; Lebriz Ersoy; Tina Schick; Joannes M. M. Groenewoud; Yara T. Lechanteur; Sascha Fauser; Carel B. Hoyng; Eiko K. de Jong; Anneke I. den Hollander
TAGS: age-related macular degeneration, complement activation, genetics, high density lipoprotein cholesterol, lipids, lipoproteins, apolipoprotein a-i, cholesterol ester transfer proteins, apolipoprotein e, single nucleotide polymorphism
Invest. Ophthalmol. Vis. Sci.. 2015; 56(13):7766-7773. doi: https://doi.org/10.1167/iovs.15-17035

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Levels of Complement Activation Differ Between Stages of Age-related Macular Degeneration.

Yara Lechanteur; Tina Schick; Joannes Groenewoud; Lebriz Ersoy; Sandra Liakopoulos; Anneke I Den Hollander; Carel C B Hoyng; B. Jeroen Klevering

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):787. doi:

ARVO Annual Meeting Abstract June 2015

Validation of a prediction model in families with age-related macular degeneration

Eveline Kersten; Yara Lechanteur; Nicole T.M. Saksens; Tina Schick; Sascha Fauser; Anneke I Den Hollander; Carel C B Hoyng

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):794. doi:

ARVO Annual Meeting Abstract June 2015

Metabolomics in AMD - identifying metabolic pathways and biomarkers for improved prediction and prevention

Eiko de Jong; Yara Lechanteur; Nicolas Schauer; Tina Schick; Sascha Fauser; Carel C B Hoyng; Anneke I Den Hollander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):395. doi:

ARVO Annual Meeting Abstract April 2014

Environmental and genetic risk factors for retinal angiomatous proliferation

Albert Caramoy; Tina Ristau; Yara T E Lechanteur; Lebriz Ersoy; Sebastian Müller; Faik Gelisken; Carel Hoyng; Bernd Kirchhof; Anneke I. Den Hollander; Sascha Fauser

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2223. doi:

Retina January 2014

Allergy Is a Protective Factor Against Age-Related Macular Degeneration

PDF

Tina Ristau; Lebriz Ersoy; Yara Lechanteur; Anneke I. den Hollander; Mohamed R. Daha; Moritz Hahn; Carel B. Hoyng; Sascha Fauser
TAGS: age-related macular degeneration, hypersensitivity, immediate hypersensitivity, cohort studies, protective factors
Invest. Ophthalmol. Vis. Sci.. 2014; 55(1):210-214. doi: https://doi.org/10.1167/iovs.13-13248

ARVO Annual Meeting Abstract June 2013

Risk Factors Associated with Earlier Age of Onset of Wet Age-related Macular Degeneration

Yara Lechanteur; Patrick van de Camp; Joannes Groenewoud; Anneke Den Hollander; B. Jeroen Klevering; Carel Hoyng

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):242. doi:

ARVO Annual Meeting Abstract June 2013

Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration

Freekje van Asten; Maroeska Rovers; Yara Lechanteur; Dzenita Smailhodzic; Philipp Muether; Anneke Den Hollander; Sascha Fauser; Carel Hoyng; Gert Jan van der Wilt; B. Jeroen Klevering

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):246. doi:

ARVO Annual Meeting Abstract June 2013

Automatic Drusen Quantification and Risk Assessment of Age-related Macular Degeneration on Color Fundus Images

Mark J J P van Grinsven; Yara Lechanteur; Johannes van de Ven; Bram van Ginneken; Carel Hoyng; Thomas Theelen; Clara Sanchez

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5496. doi:

ARVO Annual Meeting Abstract June 2013

Association of Family History with Genetic Risk Factors in Patients with Age-Related Macular Degeneration

Nicole Saksens; Yara Lechanteur; Sanne Verbakel; Joannes Groenewoud; Camiel Boon; Anneke Den Hollander; Carel Hoyng

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6170. doi:

Retina April 2013

Automatic Drusen Quantification and Risk Assessment of Age-Related Macular Degeneration on Color Fundus Images

PDF

Mark J. J. P. van Grinsven; Yara T. E. Lechanteur; Johannes P. H. van de Ven; Bram van Ginneken; Carel B. Hoyng; Thomas Theelen; Clara I. Sánchez
TAGS: color, drusen, risk assessment, age-related macular degeneration
Invest. Ophthalmol. Vis. Sci.. 2013; 54(4):3019-3027. doi: https://doi.org/10.1167/iovs.12-11449

Retina August 2012

Genetic, Behavioral, and Sociodemographic Risk Factors for Second Eye Progression in Age-Related Macular Degeneration

PDF

Yara T. E. Lechanteur; Johannes P. H. van de Ven; Dzenita Smailhodzic; Camiel J. F. Boon; B. Jeroen Klevering; Sascha Fauser; Joannes M. M. Groenewoud; Gert-Jan van der Wilt; Anneke I. den Hollander; Carel B. Hoyng
TAGS: age-related macular degeneration, eye, genetics, risk factors, body mass index procedure
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5846-5852. doi: https://doi.org/10.1167/iovs.11-7731

ARVO Annual Meeting Abstract March 2012

Short-Term Changes of Basal Laminar Drusen on Spectral-Domain Optical Coherence Tomography

Johannes P. van de Ven; Camiel J. Boon; Dzenita Smailhodzic; Yara T. Lechanteur; Anneke I. den Hollander; Carel B. Hoyng; Thomas Theelen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2899. doi:

ARVO Annual Meeting Abstract March 2012

No Association between Genotypes in Glutathione S-transferase and Age-related Macular Degeneration

Yara T. Lechanteur; Wilbert H. Peters; Rene H. te Morsche; Sascha Fauser; Anneke I. Den Hollander; Carel C. Hoyng

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3307. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Analysis of plasma HtrA1 concentrations in age-related macular degeneration

Equivalent choroidal thicknesses between eyes of patients with unilateral neovascular age-related macular degeneration who have been treated with anti-vascular endothelial growth factor: a paired eyes comparative study

Rare variants in CFH and phenotype in Age-related Macular Degeneration in the Coimbra Eye Study.

Supplement intake and plasma nutritional biomarkers reduce risk for second eye progression in age-related macular degeneration.

Complement Activation Levels Are Related to Disease Stage in AMD

Subclinical choroidal neovascularizations in fellow-eyes of exudative age-related macular degeneration patients show a decrease in retinal sensitivity over time

Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration

Levels of Complement Activation Differ Between Stages of Age-related Macular Degeneration.

Validation of a prediction model in families with age-related macular degeneration

Metabolomics in AMD - identifying metabolic pathways and biomarkers for improved prediction and prevention

Environmental and genetic risk factors for retinal angiomatous proliferation

Allergy Is a Protective Factor Against Age-Related Macular Degeneration

Risk Factors Associated with Earlier Age of Onset of Wet Age-related Macular Degeneration

Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration

Automatic Drusen Quantification and Risk Assessment of Age-related Macular Degeneration on Color Fundus Images

Association of Family History with Genetic Risk Factors in Patients with Age-Related Macular Degeneration

Automatic Drusen Quantification and Risk Assessment of Age-Related Macular Degeneration on Color Fundus Images

Genetic, Behavioral, and Sociodemographic Risk Factors for Second Eye Progression in Age-Related Macular Degeneration

Short-Term Changes of Basal Laminar Drusen on Spectral-Domain Optical Coherence Tomography

No Association between Genotypes in Glutathione S-transferase and Age-related Macular Degeneration

To View More...

You must be signed into an individual account to use this feature.